BioStem Technologies
(OTC) BSEM
BioStem Technologies Financials at a Glance
Market Cap
$82.84M
Revenue (TTM)
$235.17M
Net Income (TTM)
$20.20M
EPS (TTM)
$0.85
P/E Ratio
5.96
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$5.07
Volume
8,253
Open
$5.09
Price
$5.07
Volume
8,253
Open
$5.09
Previous Close
$5.07
Daily Range
$5.00 - $5.26
52-Week Range
$3.09 - $15.74
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$5.07
Volume
8,253
Open
$5.09
Previous Close
$5.07
Daily Range
$5.00 - $5.26
52-Week Range
$3.09 - $15.74
BSEM News
BSEM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioStem Technologies
Industry
Pharmaceuticals
Sector
Health CareEmployees
32
CEO
Jason Matuszewski
Website
www.biostemtechnologies.comHeadquarters
Pompano Beach, FL 33064, US
BSEM Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
7%
Net Income Margin
9%
Return on Equity
55%
Return on Capital
30%
Return on Assets
32%
Earnings Yield
16.78%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$82.84M
Shares Outstanding
16.34M
Volume
8.25K
Short Interest
0.00%
Avg. Volume
109.04K
Financials (TTM)
Gross Profit
$287.86M
Operating Income
$31.20M
EBITDA
$31.49M
Operating Cash Flow
$24.48M
Capital Expenditure
$426.57K
Free Cash Flow
$24.05M
Cash & ST Invst.
$22.83M
Total Debt
$4.50M
BioStem Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.47M
-87.3%
Gross Profit
$9.21M
-88.2%
Gross Margin
87.95%
N/A
Market Cap
$82.84M
N/A
Market Cap/Employee
$41.42M
N/A
Employees
2
N/A
Net Income
$761.05K
-88.8%
EBITDA
$1.53M
-83.7%
Quarterly Fundamentals
Net Cash
$23.77M
+134.6%
Accounts Receivable
$20.10M
-75.2%
Inventory
$2.73M
+31.6%
Long Term Debt
$158.40K
-55.8%
Short Term Debt
$3.23M
-21.7%
Return on Assets
32.38%
N/A
Return on Invested Capital
30.48%
N/A
Free Cash Flow
$4.80M
-151.4%
Operating Cash Flow
$2.38M
-125.2%